Sun Pharmaceutical Industries Ltd. has announced the largest acquisition ever by an Indian pharmaceutical firm, agreeing to acquire US-listed Organon & Co. in an all-cash deal valued at an enterprise value of USD 11.75 billion. The transaction, priced at USD 14 per share, represents a major strategic shift as Sun Pharma accelerates its transformation into a diversified global drugmaker.
...